
Biomedicines, Journal Year: 2024, Volume and Issue: 12(11), P. 2553 - 2553
Published: Nov. 8, 2024
Inherited arrhythmogenic syndromes comprise a heterogenic group of genetic entities that lead to malignant arrhythmias and sudden cardiac death. Genetic testing has become crucial understand the disease etiology allow for early identification relatives at risk; however, it requires an accurate interpretation data achieve clinically actionable outcome. This is particularly challenging large number rare variants obtained by current high-throughput techniques, which are mostly classified as unknown significance.
Language: Английский